A federal court ruled against McKesson Corporation in a False Claims Act lawsuit, potentially broadening the scope of discovery. This decision may permit access to communications with legal counsel previously protected by attorney-client privilege.
The court determined McKesson put its legal advice and good-faith beliefs at issue during litigation.
The lawsuit was initially filed in 2012. It alleges McKesson engaged in a scheme involving the repackaging and improper handling of oncology medications.
These actions allegedly led to the submission of false claims to federal healthcare programs. The case is currently fully briefed for summary judgment.